Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00371033 · ClinicalTrials.gov registry record · Phase 3
Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
A Phase 3 study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- Phase 3
- Development phase
- 324
- Enrollment target
- 11
- Study locations
NCT00371033 is a Phase 3 study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 324 participants. The trial reports 11 study locations across 9 states.
The verdict
NCT00371033, a Phase 3 study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS), has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 324 participants
- Enrollment target
- 11
- Study locations
Study Summary
The purpose of this study is to determine whether pregabalin is an effective treatment for Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Pregabalin
Study Locations (11)
California
- Charles R Drew University of Medicine & Science - Los Angeles
- David Geffen School of Medicine at UCLA - Los Angeles
- Stanford University Medical Center - Stanford
Illinois
- Northwestern University Feinberg School of Medicine - Chicago
Maryland
- University of Maryland - Baltimore
Massachusetts
- Harvard Medical School - Boston
Mississippi
- University of Mississippi Medical Center - Jackson
Ohio
- Cleveland Clinic Foundation - Cleveland
Pennsylvania
- Temple University School of Medicine - Philadelphia
Washington
- University of Washington Harborview Medical Center - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 324 participants |
| Start Date | 2006-03 |
| Est. Completion | 2008-04-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00371033
The ClinicalTrials.gov registry entry for NCT00371033 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 324 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00371033 reports 11 study locations spanning 9 distinct geographic areas - top geographies include California, Illinois, Maryland.
Frequently Asked Questions
What is clinical trial NCT00371033 about?
NCT00371033 is a clinical study titled "Efficacy & Safety Study of Pregabalin to Treat Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)". The purpose of this study is to determine whether pregabalin is an effective treatment for Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
What is the current status of trial NCT00371033?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 324 participants. The study started on 2006-03. Estimated completion is 2008-04-30.
What conditions does trial NCT00371033 study?
This clinical trial studies the following conditions: Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS).
What interventions are being tested in trial NCT00371033?
The interventions under investigation include: Placebo (DRUG), Pregabalin (DRUG).
Who is sponsoring clinical trial NCT00371033?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00371033 being conducted?
This trial has 11 study locations across California, Illinois, Maryland, Massachusetts, Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.